Tryptophan Catabolism is Unaffected in Chronic Granulomatous Disease

Maghzal, Ghassan J.,Winter, Susann,Wurzer, Bettina,Chong, Beng H.,Holmdahl, Rikard,Stocker, Roland
DOI: https://doi.org/10.1038/nature13844
IF: 64.8
2014-01-01
Nature
Abstract:Arising from L. Romani et al. 211–215 (2008); doi:10.1038/nature06471 Chronic granulomatous disease (CGD) is an inherited disorder of phagocyte function, caused by a genetic defect in NADPH oxidase (NOX2), leading to an impaired ability of leukocytes to produce superoxide ( )1; CGD subjects are susceptible to chronic infections and hyper-inflammation, although the mechanisms remain unclear. Romani et al.2 reported an aberrant inflammatory response to pulmonary aspergillosis as well as sterile Aspergillus fumigatus to be mediated by a defective tryptophan catabolism to kynurenine caused by lack of in CGD mice. Kynurenine is formed by indoleamine 2,3-dioxygenase-1 (IDO1) in a reaction originally reported to depend on (ref. 3). Here we show that NOX2 deficiency does not attenuate IDO1-mediated tryptophan catabolism in human phagocytes and CGD mice with granulomas arising from an inflammatory response to Aspergillus. There is a Reply to this Brief Communications Arising by Romani, L. & Puccetti, P. Nature 514, http://dx.doi.org/10.1038/nature13845 (2014).
What problem does this paper attempt to address?